Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Down Syndrome
|
80 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Dyslipidemias
|
184 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.020 | 1.000 | 2 | 2014 | 2015 | ||||
Endometrial Carcinoma
|
326 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Endometrial Hyperplasia
|
6 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Exudative age-related macular degeneration
|
109 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
exudative macular degeneration
|
69 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Geographic Atrophy
|
81 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Hepatolenticular Degeneration
|
349 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
High density lipoprotein measurement
|
1440 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 4 | 2015 | 2018 | ||||
Hypercholesterolemia
|
123 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.020 | 0.500 | 2 | 1993 | 2001 | ||||
Hyperlipidemia
|
83 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.010 | 1.000 | 1 | 1988 | 1988 | ||||
Hyperlipoproteinemia Type IIa
|
661 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Hyperlipoproteinemia Type III
|
24 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.730 | 1.000 | 3 | 1988 | 1994 | ||||
Hyperlipoproteinemias
|
7 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||
Hyperopia
|
29 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||
Hypertensive disease
|
1085 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.710 | 1.000 | 2 | 2019 | 2019 | ||||
Hypertriglyceridemia
|
169 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.040 | 0.750 | 4 | 1993 | 2004 | ||||
Impaired cognition
|
348 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Ischemic stroke
|
704 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Lewy Body Disease
|
41 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 3 | 2014 | 2019 | ||||
Longevity
|
74 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 2 | 2018 | 2018 | ||||
Memory performance
|
71 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||
Mental deterioration
|
121 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.710 | 1.000 | 2 | 2017 | 2019 | ||||
Metabolic Syndrome X
|
591 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.020 | 0.500 | 2 | 2011 | 2014 |